Cargando…
Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930264/ https://www.ncbi.nlm.nih.gov/pubmed/33658480 http://dx.doi.org/10.1038/s41419-021-03420-5 |
| _version_ | 1783660074826203136 |
|---|---|
| author | Wei, Lusheng Ye, Huilin Li, Guolin Lu, Yuanting Zhou, Quanbo Zheng, Shangyou Lin, Qing Liu, Yimin Li, Zhihua Chen, Rufu |
| author_facet | Wei, Lusheng Ye, Huilin Li, Guolin Lu, Yuanting Zhou, Quanbo Zheng, Shangyou Lin, Qing Liu, Yimin Li, Zhihua Chen, Rufu |
| author_sort | Wei, Lusheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7930264 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79302642021-03-19 Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer Wei, Lusheng Ye, Huilin Li, Guolin Lu, Yuanting Zhou, Quanbo Zheng, Shangyou Lin, Qing Liu, Yimin Li, Zhihua Chen, Rufu Cell Death Dis Correction Nature Publishing Group UK 2021-03-03 /pmc/articles/PMC7930264/ /pubmed/33658480 http://dx.doi.org/10.1038/s41419-021-03420-5 Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Wei, Lusheng Ye, Huilin Li, Guolin Lu, Yuanting Zhou, Quanbo Zheng, Shangyou Lin, Qing Liu, Yimin Li, Zhihua Chen, Rufu Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer |
| title | Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer |
| title_full | Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer |
| title_fullStr | Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer |
| title_full_unstemmed | Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer |
| title_short | Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer |
| title_sort | correction: cancer-associated fibroblasts promote progression and gemcitabine resistance via the sdf-1/satb-1 pathway in pancreatic cancer |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930264/ https://www.ncbi.nlm.nih.gov/pubmed/33658480 http://dx.doi.org/10.1038/s41419-021-03420-5 |
| work_keys_str_mv | AT weilusheng correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT yehuilin correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT liguolin correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT luyuanting correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT zhouquanbo correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT zhengshangyou correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT linqing correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT liuyimin correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT lizhihua correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer AT chenrufu correctioncancerassociatedfibroblastspromoteprogressionandgemcitabineresistanceviathesdf1satb1pathwayinpancreaticcancer |